New wrinkle treatment combo shows promise in early trial

NCT ID NCT06834789

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-stage study tested whether a new drug called AGN-151586 can be safely combined with BOTOX to treat moderate to severe frown lines between the eyebrows. Researchers monitored 132 healthy adults for side effects and immune responses after a single treatment session. The goal was to check safety and see if the combination works better than BOTOX alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLABELLAR LINES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Austin Institute for Clinical Research - Pflugerville /ID# 270834

    Pflugerville, Texas, 78660, United States

  • Eye Research Foundation /ID# 270827

    Newport Beach, California, 92663, United States

  • Investigate MD /ID# 270771

    Scottsdale, Arizona, 85260, United States

  • Marcus Facial Plastic Surgery /ID# 270770

    Redondo Beach, California, 90277, United States

  • Skin Research Institute LLC /ID# 270831

    Coral Gables, Florida, 33146-1837, United States

  • SkinDC /ID# 270932

    Arlington, Virginia, 22209, United States

  • Skincare Physicians /ID# 271018

    Chestnut Hill, Massachusetts, 02467, United States

  • Wilmington Dermatology Center /ID# 270828

    Wilmington, North Carolina, 28403, United States